54. Amyloid-α Peptide Formed through Alternative Processing of the Amyloid Precursor Protein Attenuates Alzheimer’s Amyloid-β Toxicity via Cross-Chaperoning Ariel J Kuhn, Ka Chan, Maria Sajimon, Stan Yoo, Vitor Hugo Balasco Serrão, Jack Lee, Benjamin Abrams, James S Nowick, Vladimir N Uversky, Christopher Wheeler, Jevgenij A Raskatov Journal of the American Chemical Society, 2024, 146 (4), 2634-2645

53. Racemic Peptides from Amyloid β and Amylin Form Rippled β-Sheets Rather Than Pleated β-Sheets Amaruka Hazari, Michael R. Sawaya, Maria Sajimon, Niko Vlahakis, Jose Rodriguez, David Eisenberg, Jevgenij A. Raskatov. Journal of the American Chemical Society 2023, 145 (47) , 25917-25926

52. A Crystal-Structural Study of Pauling-Corey Rippled Sheets Ariel J. Kuhn, Beatriz Ehlke, Timothy C. Johnstone, Scott Oliver, Jevgenij A. Raskatov Chem. Sci., 2021, 54, 10, 2488–2501

51. Defining the Landscape of the Pauling-Corey Rippled Sheet: An Orphaned Motif Finding New Homes Jevgenij A. Raskatov, Joel P. Schneider, Bradley L. Nilsson Acc. Chem. Res. 2021, 54, 10, 2488–2501

50. Constraints on the Structure of Fibrils Formed by a Racemic Mixture of Amyloid-β Peptides from Solid-State NMR, Electron Microscopy, and Theory Jevgenij A. Raskatov, Alejandro R. Foley, John M. Louis, Wai-Ming Yau, Robert Tycko J. Am. Chem. Soc. 2021, 143, 33, 13299–13313

49. Understanding and Controlling Amyloid Aggregation with Chirality Alejandro R. Foley, Jevgenij A. Raskatov Curr Opin Chem Biol 2021, 64, 1-9

48. A DFT Study of Structure and Stability of Pleated and Rippled Cross‐β Sheets with Hydrophobic Sidechains Jevgenij A. Raskatov Biopolymers 2020, 112(1), e23391

47. Evidence for Aggregation Independent, PrP^C-mediated Aβ Cellular Internalization Alejandro R. Foley, Graham P. Roseman, Ka Chan, Amanda Smart, Thomas S. Finn, Kevin Yang,  R. Scott Lokey, Glenn L. Millhauser, Jevgenij A. Raskatov Proc. Natl. Acad. Sci. USA 2020, 117 (46), 28625-28631

46. Conformational Selection as the Driving Force of Amyloid β Chiral Inactivation Jevgenij A. Raskatov ChemBioChem 2020, 21(20), 2945-2949

45. Alzheimer’s Disease “Non-amyloidogenic” p3 Peptide Revisited: A Case for Amyloid-α Ariel J. Kuhn, Benjamin S. Abrams, Stella Knowlton, Jevgenij A. Raskatov ACS. Chem. Neurosci. 2020, 11(11), 1539-1544

44. Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer’s Disease?  Ariel J. Kuhn, Jevgenij A. Raskatov J. Alzheimers Dis. 2020, 74, 43-53

43. Assessing Reproducibility on Amyloid β Research: Impact of Aβ Sources in Experimental Outcomes Alejandro R. Foley, Jevgenij A. Raskatov ChemBioChem 2020, 21, 2425-2430

42. A Focused Chiral Mutant Library of the Amyloid β 42 Central Electrostatic Cluster as a Tool to Stabilize Aggregation Intermediates Alejandro R. Foley, Hsiau-Wei Lee, Jevgenij A. Raskatov J. Org. Chem. 2020, 85, 1385-1391

41. A Facile Method for Separation of the Cryptic Methionine Sulfoxide Diastereomers, Structural Assignment and DFT Analysis Jevgenij A. Raskatov, Scott Virgil, Hsiau-Wei Lee, Laurence M. Henling, Ka Chan,  Ariel J. Kuhn, Alejandro R. Foley Chem. Eur. J. 2020, 26, 4467-4470

40. New Insights into Differential Aggregation of Enantiomerically Pure and Racemic Aβ40 Systems S. Dutta, Alejandro R. Foley, Ariel J. Kuhn, Benjamin Abrams, Hsiau-Wei Lee, J. A. Raskatov Pept. Sci. 2019, e24139

39. Trapping and Characterization of Nontoxic Aβ42 Aggregation Intermediates Alejandro R. Foley, Thomas S. Finn, Timothy Kung, Asa Hatami, Hsiau-Wei Lee, Manping Jia, Marco Rolandi, J. A. Raskatov ACS Chem. Neurosci. 2019, 10, 8, 3880-3887

38. Using Mirror-Image Peptides to Enhance Robustness and Reproducibility in Studying the Amyloid β-Proteins Ariel J. Kuhn, J. A. Raskatov Prog. Mol. Biol. Transl. Sci. 2019, 168, 57-67

37. What is the “Relevant” Amyloid β 42 Concentration? J. A. Raskatov ChemBioChem 2019, 20, 1725-1726

36. A DFT-assisted Topological Analysis of Four Polymorphic, S-shaped Aβ42 Fibril Structures Alejandro R. Foley, J. A. Raskatov ChemBioChem 2019, 20, 1722-1724

35. Chirality Dependence of Amyloid β Cellular Uptake and a New Mechanistic Perspective S. Dutta, Thomas S. Finn, Ariel J. Kuhn, Benjamin Abrams, J. A. Raskatov ChemBioChem 2018, 20, 1023-1026

34. Chiral Conversion of Amyloid Proteins Associated with Diseases(PATENT) J. A. Raskatov 2018, US Patent Application No. 15/754,942.

33. Chiral Inactivation: An Old Phenomenon with a New Twist J. A. Raskatov Chem. Eur. J. 2017, 23, 16920-16923

32. Using Chirality to Probe the Conformational Dynamics and Assembly of Intrinsically Disordered Amyloid Proteins J. A. Raskatov, D. B. Teplow Sci. Rep. 2017, 7, 12433

31. Suppression of Oligomer Formation and Formation of Non-Toxic Fibrils upon Addition of Mirror-Image Aβ42 to the Natural L-Enantiomer S. Dutta, Alejandro R. Foley, C. J. A. Warner, Xiaolin Zhang, Marco Rolandi, Benjamin Abrams, J. A. Raskatov Angew. Chem. Int. Ed. 2017, 56, 11506-11510

30. A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation C. J. A. Warner, S. Dutta, Alejandro R. Foley, J. A. Raskatov J. Vis. Exp. 2017, e55482

29. Using Chiral Peptide Substitutions to Probe the Structure Function Relationship of a Key Residue of Aβ42 C. J. A. Warner, S. Dutta, Alejandro R. Foley, Eefei Chen, David S. Kliger, J. A. Raskatov Chirality 2017, 29, 5-9

28. Introduction of D-glutamate at a Critical Residue of Aβ42 Stabilizes a Pre-fibrillary Aggregate with Enhanced Toxicity C. J. A. Warner, S. Dutta, Alejandro R. Foley, J. A. Raskatov Chem. Eur. J. 2016, 22, 11967-11970

27. Strict Regio-specificity of Human Epithelial 15-Lipoxygenase-2 Delineates its Transcellular Synthesis Potential A. R. Green, S. Barbour, T. Horn, J. Carlos, J. A. Raskatov, T. R. Holman Biochemistry 2016, 55, 2832-2840

26. 4-Azidobenzyl Ferrocenylcarbamate as an Anticancer Prodrug Activated at Reductive Conditions E. Kinski, P. Marzenell, W. Hofer, J. A. Raskatov, K. X. Knaup, E. M. Zolnhofer, K. Meyer, A. Mokhir J. Inorg. Biochem. 2016, 160, 218-224

25. An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors J. O. Szablowski, J. A. Raskatov, P. B. Dervan Mol. Cancer Ther. 2016, 15, 608-617

24. Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams Against Trypanosoma brucei C. J. Schulze, M. S. Donia, J. L. S. Neto, D. Ray, J. A. Raskatov, R. E. Green, J. H. McKerrow, M. A. Fischbach, R. G. Linington ACS Chem. Biol. 2015, 10, 2373-2381

23. Tumor Xenograft Uptake of a Py-Im Polyamide Varies as a Function of Cell Line Grafted: a C-14 Study J. A. Raskatov, J. O. Szablowski, P. B. Dervan J. Med. Chem. 2014, 57, 8471-8476

22. A C-14 Labeled Py-Im Polyamide Localizes to a Subcutaneous Prostate Cancer Tumor J. A. Raskatov, J. W. Puckett, P. B. Dervan Bioorg. Med. Chem. 2014, 22, 4371-4375

21. Chiral Recognition in Contact Ion-pairs; Observation, Characterization and Analysis J. A. Raskatov, A. L. Thompson, A. R. Cowley, T. D. W. Claridge, J. M. Brown Chem. Sci. 2013, 4, 3140-3147

20. Activity of a Py-Im Polyamide Targeted to the Estrogen Response Element N. G. Nickols, J. O. Szablowski, A. E. Hargrove, B. C. Li, J. A. Raskatov, P. B. Dervan Mol. Cancer. Ther., 2013, 12, 675-684

19. Gene Expression Changes in a Tumor Xenograft by a Py-Im Polyamide J. A. Raskatov, N. G. Nickols, A. E. Hargrove, G. K. Marinov, B. Wold, P. B. Dervan Proc. Natl. Acad. Sci. USA 2012, 109, 16041-16045

18. Iridium-Catalyzed Allylic Substitutions with Cyclometallated Phosphoramidite Complexes Bearing a Dibenzocyclooctatetraene Ligand – Preparation of (π-Allyl)Ir Complexes, Computational and NMR-Spectroscopic Studies J. A. Raskatov, M. Jaekel, B. Straub, F. Rominger, G. Helmchen Chem. Eur. J. 2012, 18, 14314-14328

17. Characterization and Solubilization of Pyrrole-Imidazole Polyamide Aggregates A. E. Hargrove, J. A. Raskatov, J. L. Meier, D. Montgomery, P. B. Dervan J. Med. Chem. 2012, 55, 5425-5432

16. Pharmacokinetics of Py-Im Polyamides Depend on Architecture: Cyclic versus Linear J. A. Raskatov, A. E. Hargrove, A. Y. So, P. B. Dervan J. Am. Chem. Soc. 2012, 134, 7995-7999

15. Modulation of NF-κB-Dependent Gene Transcription Using Programmable DNA Minor Groove Binders J. A. Raskatov, J. L. Meier, J. W. Puckett, F. Yang, P. Ramakrishnan, P. B. Dervan Proc. Natl. Acad. Sci.USA 2012, 109, 1023-1028

14. The Origins of Enantioselectivity in Rh-diene Complex Catalyzed Arylation of Cyclohex-2-enones S. Gosiewska, J. A. Raskatov, R. Shintani, T. Hayashi, J. M. Brown Chem. Eur. J. 2012, 18, 80-84

13. Expanding the Repertoire of Natural Product-Inspired Ring Pairs for Molecular Recognition of DNA K. A. Muzikar, J. L. Meier, D. A. Gubler, J. A. Raskatov, P. B. Dervan Org. Lett. 2011, 13, 5612-5615

12. Effects of Substituents on the Regioselectivity of Palladium-Catalysed Allylic Substitutions – A DFT Study J. A. Raskatov, G. Helmchen Modeling of Molecular Properties, First Edition. Edited by Peter Comba; Wiley-VCH 2011, pp 191-206

11. Chiral Selection in the Formation of Borates From Racemic Binaphthols and Related Diols J. A. Raskatov, A. L. Thompson, J. M. Brown Cryst. Eng. Comm. 2011, 13, 2923-2929

10. Exploring the Reactions of CO2 with PCP Supported Nickel Complexes T. J. Schmeier, N. Hazari, C. D. Incarvito, J. A. Raskatov Chem. Commun. 2011, 47, 1824-1826

9. Asymmetric Catalysis with 7-Ring Chelate Diphosphines: DIOP, BINAP and Conformational Mobility J. A. Raskatov, A. L. Thompson, J. M. Brown Tetrahedron Asymm. 2010, 21, 1737-1744

8. Ir-Catalyzed Asymmetric Allylic Substitutions with Cyclometallated (Phosphoramidite)Ir-Complexes – Resting States, Catalytically Active (π-Allyl)Ir-Complexes and Computational Exploration J. A. Raskatov, S. Spiess, C. Gnamm, K. Broedner, F. Rominger, G. Helmchen Chem. Eur. J. 2010, 16, 6601-6615

7. Determination of the Conformation of the Key-Intermediate of an Enantioselective Pd-catalysed Allylic Substitution from Residual Dipolar Couplings B. Boettcher, V. Schmidts, J. A. Raskatov, C. M. Thiele Angew. Chem. Int. Ed. 2010, 49, 205-209

6. Ir-Catalyzed Asymmetric Allylic Substitutions with (Phosphoramidite)Ir-Complexes – Resting States, Synthesis und Characterization of Catalytically Active (π-Allyl)Ir-Complexes S. Spiess, J. A. Raskatov, C. Gnamm, K. Broedner, G. Helmchen Chem. Eur. J. 2009, 15, 11087-11090

5. CpCo Mediated Reactions of Cyclopropenones: A DFT Study D. B. Werz, G. Klatt, J. A. Raskatov, H. Koeppel, R. Gleiter Organometallics 2009, 28, 1675-1682

4. Synthesis and Rhodium Complexation of Enantiomerically Pure Bicyclo 3.3.1]nona-2,6-diene M. Mayr, C. Bataille, S. Gosiewska, J. A. Raskatov, J. M. Brown Tet. Asymm. 2008, 19, 1328-1332

3. DFT Calculations on Cyclacenes and CpCo-Capped Cyclacenes B. Esser, J. A. Raskatov, R. Gleiter Org. Lett. 2007, 9, 4037-4040

2. Thin-layer Chromatography Analysis of Lipids (Dünnschichtchromatographische Analyse von Lipiden) T. Appel, G. Gellermann, C. Leisner, T. Lütkepohl, J. A. Raskatov, J. Rossa a) GIT Laborfachzeitschrift 2003, 1140-1142; b) GIT LaborMedizin & Diagnostik

1. 2004 Quantitative Lipid Analysis via High Performance Thin-Layer Chromatography (Quantitative Analyse von Lipiden durch hochauflösende Dünnschichtchromategraphie) J. A. Raskatov, J. Rossa, T. Appel Chemie in Labor und Biotechnik 2002, 7, M49-M55